Tuesday, October 14, 2008 - 1:05AM EST

Clinical Trials

1. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.

Author
Garrido P; Gonzalez-Larriba JL; Insa A; Provencio M; Torres A; Isla D; Sanchez JM; Cardenal F; Domine M; Barcelo JR; Tarrazona V; Varela A; Aguilo R; Astudillo J; Muguruza I; Artal A; Hernando-Trancho F; Massuti B; Sanchez-Ronco M; Rosell R;
Institution
Hospital Ramon y Cajal, Madrid, Spain.
Journal
J Clin Oncol. 2007 Oct 20;25(30):4736-42.
Abstract URL
Click here to view abstract

2. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.

Author
Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M; Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M;
Institution
The First Department of Internal Medicine, Showa University School of Medicine, Shinagawa, Tokyo, Japan. thirose-shw@umin.ac.jp
Journal
Cancer Chemother Pharmacol. 2006 Sep;58(3):361-7. Epub 2005 Dec 6.
Abstract URL
Click here to view abstract

3. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.

Author
Ichiki M; Kawasaki M; Takayama K; Ninomiya K; Kuba M; Iwami F; Miyazaki N; Oishi K; Takeo S; Aizawa H; Nakanishi Y;
Institution
Department of Respiratory Medicine, National Hospital Organization Kyushu Medical Center, Chuo-ku, Fukuoka, Japan. ichiki@qmed.hosp.go.jp
Journal
Cancer Chemother Pharmacol. 2006 Sep;58(3):368-73. Epub 2006 Jan 4.
Abstract URL
Click here to view abstract

4. Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer.

Author
Nemunaitis J; Jahan T; Ross H; Sterman D; Richards D; Fox B; Jablons D; Aimi J; Lin A; Hege K;
Institution
Mary Crowley Medical Research Center, Baylor University Medical Center, Texas Oncology PA, Dallas, TX 75201, USA. jnemunaitis@mcmrc.com
Journal
Cancer Gene Ther. 2006 Jun;13(6):555-62.
Abstract URL
Click here to view abstract

5. Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer.

Author
Yamamoto N; Nishimura Y; Nakagawa K; Matsui K; Fukuoka M;
Institution
Medical Oncology, Kinki University School of Medicine, Osaka, Japan. n.yamamoto@scchr.jp
Journal
Cancer Chemother Pharmacol. 2006 Sep;58(3):285-91. Epub 2006 Jan 17.
Abstract URL
Click here to view abstract

6. High-dose proton beam therapy for Stage I non-small-cell lung cancer.

Author
Nihei K; Ogino T; Ishikura S; Nishimura H;
Institution
Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. knihei@east.ncc.go.jp
Journal
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):107-11. Epub 2006 Feb 3.
Abstract URL
Click here to view abstract

7. Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.

Author
Ritch P; Rudin CM; Bitran JD; Edelman MJ; Makalinao A; Irwin D; Lilenbaum R; Peterson P; John WJ;
Institution
Milwaukee Medical College, Milwaukee, USA.
Journal
Lung Cancer. 2006 May;52(2):173-80. Epub 2006 Feb 28.
Abstract URL
Click here to view abstract

8. Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study.

Author
Roselli M; Mariotti S; Ferroni P; Laudisi A; Mineo D; Pompeo E; Ambrogi V; Mineo TC;
Institution
Medical Oncology, Department of Internal Medicine, Policlinico Tor Vergata University, Rome, Italy. mario.roselli@ptvonline.it
Journal
Int J Cancer. 2006 Aug 15;119(4):955-60.
Abstract URL
Click here to view abstract

9. Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.

Author
Koukourakis MI; Patlakas G; Froudarakis ME; Kyrgias G; Skarlatos J; Abatzoglou I; Bougioukas G; Bouros D;
Institution
Department of Radiotherapy/Oncology, Democritus University of Thrace, Medical School, Alexandroupolis, Greece. targ@her.forthnet.gr
Journal
Anticancer Res. 2007 Sep-Oct;27(5B):3625-31.
Abstract URL
Click here to view abstract

10. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

Author
Gilligan D; Nicolson M; Smith I; Groen H; Dalesio O; Goldstraw P; Hatton M; Hopwood P; Manegold C; Schramel F; Smit H; van Meerbeeck J; Nankivell M; Parmar M; Pugh C; Stephens R;
Institution
Addenbrooke's Hospital, Cambridge, UK.
Journal
Lancet. 2007 Jun 9;369(9577):1929-37.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10 11 12